SCA-136

DRUG4 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

HealthySchizophrenia

Phase 1

Study Evaluating SCA-136 Tolerability With Dose Titration and Food

TerminatedNCT00420706

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-12-31End: 2006-12-31Target: 120Updated: 2007-12-10

Safety, PK and PD Study in Healthy Male Japanese Subjects

CompletedNCT00447941

Wyeth is now a wholly owned subsidiary of PfizerSchizophrenia

Start: 2006-06-30End: 2006-08-31Target: 24Updated: 2009-08-07

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

CompletedNCT00458107

Wyeth is now a wholly owned subsidiary of PfizerSchizophrenia

Start: 2007-04-30End: 2007-09-30Target: 64Updated: 2007-12-05

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

CompletedNCT00505973

Wyeth is now a wholly owned subsidiary of PfizerSchizophrenia

Start: 2007-07-31End: 2007-10-31Target: 24Updated: 2007-12-05